Grappling with the long-term care market

Alzheimer’s therapy remains out of reach One of the bigger drivers of long term care – Alzheimer’s disease – is the target of nearly 100 drug development programs, according to InSight Pharma Reports (Needham, MA). But a successful product is […]

Read More

Building bridges to rare disease patients

Have you noticed that interest in rare disease product development isn’t as “rare” as it used to be? Currently about one-third of the drug development pipeline is targeting rare (or “orphan”—the two are used interchangeably) diseases, which are defined as […]

Read More

Cloud computing enables true multichannel marketing

For the last 10 years, the technology that marketers need to successfully create, execute, measure and enhance multichannel marketing programs has fallen short. Some might even argue that the distractions of rapidly developing technologies around social media and mobile communications […]

Read More